Rockefeller Capital Management
BIOR

Rockefeller Capital Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Rockefeller Capital Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed – – 4222
2022
Q4 		$0 Hold
1
– – ﹤0.01% 4365
2022
Q3 		$0 Buy
+1
New +$180 ﹤0.01% 4564
2022
Q2 		– Hold
0
– – – 4524
2022
Q1 		– Hold
0
– – – 4160
2021
Q4 		– Hold
0
– – – 4076

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Rockefeller Capital Management's BIOR Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2023, closing a stake of 1 share.

Rockefeller Capital Management first reported a position in BIOR in Q3 2022 and held it in 2 quarters. The position peaked at $0 in Q4 2022. 30 funds tracked by Wall St. Rank hold BIOR as of Q1 2023.

  • Rockefeller Capital Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Rockefeller Capital Management sold 1 Biora Therapeutics, Inc. Common Stock share in Q1 2023.
  • Rockefeller Capital Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Rockefeller Capital Management's Biora Therapeutics, Inc. Common Stock position peaked at $0 in Q4 2022.
  • 30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.